The Top 10 Pitfalls in Initiating Advanced Therapy in IBD
Tools to Optimize Patient Outcomes
Achieving mucosal healing in inflammatory bowel diseases: which drug concentrations need to be targeted?
Van den Berghe N, et al. Clin Pharmacol Ther. 2019;106(5):945-954.
The role of mucosal healing in the treatment of patients with inflammatory bowel disease.
Vaughn BP, et al. Curr Treat Options Gastroenterol. 2014;12(1):103-117.
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, et al. Lancet Gastroenterol Hepatol. 2024;9(5):415-427.
Shared decision-making in the management of patients with inflammatory bowel disease.
Song K, Wu D. World J Gastroenterol. 2022;28(26):3092-3100.
Communicating risk to patients and the public.
Naik G, et al. Br J Gen Pract. 2012;62(597):213-216.
Medical and social determinants of health as predictors of adverse outcomes in patients with inflammatory bowel disease.
Shah R, et al. Proc (Bayl Univ Med Cent). 2022;36(2):165-170.
Social determinants of health literature summaries.
US Department of Health and Human Services. Healthy People 2030. 2024.
Racial disparities in utilization of specialist care and medications in inflammatory bowel disease.
Nguyen GC, et al. Am J Gastroenterol. 2010;105(10):2202-2208.
GUIDELINES
AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s disease.
Ananthakrishnan AN, et al. Gastroenterology. 2023;165(6):1367-1399.
ACG clinical guideline: management of Crohn's disease in adults.
Lichtenstein GR, et al. Am J Gastroenterol. 2018;113(4):481-517.
ECCO guidelines on therapeutics in Crohn’s disease: medical treatment.
Gordon H, et al. J Crohns Colitis. 2024;jjae091.
AGA living guidelines: pharmacological management of moderate-to-severe ulcerative colitis.
Singh S, et al. Gastroenterology. 2024. [epub before print]
ACG clinical guideline: ulcerative colitis in adults.
Rubin DT, et al. Am J Gastroenterol. 2019;114(3):384-413.
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment.
Raine T, et al. J Crohns Colitis. 2022;16(1):2–17.
PATIENT RESOURCES AND ADVOCACY ORGANIZATIONS
American College of Gastroenterology
American Gastroenterological Association
Crohn’s and Colitis Foundation
European Crohn’s and Colitis Organisation
The Top 10 Pitfalls in Initiating Advanced Therapy in IBD
Tools to Optimize Patient Outcomes
| Faculty: | Bruce E. Sands, MD, MS |
| Release: | 09/18/2024 |
| Expiration: | 09/18/2025 |
